WEO Media vs Becton Dickinson
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dental marketing agency providing websites, SEO, PPC, and patient communication for dental practices in the US and Canada. Beaverton OR; founded 2009;
About
WEO Media is a Beaverton, Oregon-based dental-specific marketing agency and technology company that provides website design, search engine optimization, pay-per-click advertising, online reputation management, and patient communication tools to dental practices across the United States and Canada. Founded in 2009, WEO Media built its business around the unique marketing needs of independent dental practices and DSO-affiliated offices, which differ significantly from general small business marketing in their emphasis on local search visibility, treatment-specific landing pages, patient reviews, and HIPAA-compliant communication. The company combines managed digital marketing services with proprietary technology tools for patient communication and review generation, offering dental practices a full-service growth marketing partner.\n\nWEO Media's website platform is purpose-built for dental practices, with built-in features for treatment page templates, appointment request forms, before-and-after gallery management, and ADA accessibility compliance. The company's SEO methodology focuses on local search dominance—ensuring that each dental practice ranks prominently for high-intent searches like "dentist near me," "dental implants [city]," and "emergency dentist [neighborhood]"—which drives the majority of new patient acquisition for most dental offices. WEO Media manages Google Business Profiles, local citation building, and online review acquisition campaigns as integrated components of its local SEO service.\n\nWEO Media targets independent dental practices and small group practices that want to outsource their digital marketing to a specialist with deep dental industry knowledge rather than working with a general digital marketing agency that lacks familiarity with dental treatment marketing, HIPAA compliance requirements, and the competitive dynamics of local dental markets. The company competes with ProSites, TNT Dental, and PatientSites in the dental marketing agency space, as well as with in-house marketing capabilities at larger DSOs. WEO Media differentiates on its combination of managed services and proprietary technology and its long track record in the dental market.
Franklin Lakes NJ medical technology (NYSE: BDX) at $21.8B FY2025 revenue (+8.2%); $17.5B Reverse Morris Trust spinoff with Waters (2025), Edwards critical care acquisition $4.2B (2024) competing with Baxter for infusion systems.
About
Becton, Dickinson and Company (BD) is a Franklin Lakes, New Jersey-based global medical technology company — publicly traded on the New York Stock Exchange (NYSE: BDX) as an S&P 500 Health Care component — manufacturing and selling medical supplies, devices, laboratory equipment, and diagnostic products through approximately 74,000 employees serving healthcare institutions, clinical laboratories, pharmaceutical companies, and life science researchers in over 190 countries. In fiscal year 2025 (ended September 30, 2025), BD reported full-year revenue of $21.8 billion (up 8.2% year-over-year) with Q4 FY2025 revenue of $5.9 billion (+8.3% reported, +3.9% organic growth), and declared a quarterly dividend of $1.05 per share (+1%). Founded in 1897 in New York City by Maxwell Becton and Fairleigh Dickinson Sr. as a thermometer and surgical instrument maker, BD has grown through 125+ years of acquisitions to become a Fortune 500 ($21.8B revenue, #211 on 2024 Fortune 500) global medtech leader. The company operates through three segments: BD Medical (~50% of revenue, IV catheters, syringes, prefillable drug delivery systems, and medication management solutions), BD Life Sciences (flow cytometry, microbiology, molecular diagnostics, and lab automation), and BD Interventional (advanced patient monitoring, interventional cardiology, and peripheral vascular interventions). BD invests $1.2+ billion annually in R&D. In 2024, BD acquired Edwards Lifesciences' critical care monitoring unit for $4.2 billion.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.